(Q37529527)

20 August 2017

1 reference

title

Homocysteine levels and amyotrophic lateral sclerosis: A possible link (English)

1 reference

amyotrophic lateral sclerosis

20 August 2017

main subject

0 references

3

Ettore Beghi

1 reference

20 August 2017

4

Giancarlo Logroscino

1 reference

20 August 2017

Stefano Zoccolella

1

1 reference

20 August 2017

Caterina Bendotti

series ordinal

2

1 reference

20 August 2017

publication date

1 January 2010

1 reference

Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders

20 August 2017

published in

1 reference

20 August 2017

volume

11

1 reference

20 August 2017

issue

1-2

1 reference

20 August 2017

page(s)

140-147

1 reference

Vascular dysfunction in hyperhomocyst(e)inemia. Implications for atherothrombotic disease

20 August 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F17482960902919360

Homocysteine and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F17482960902919360

Plasma homocysteine as a risk factor for dementia and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F17482960902919360

Homocysteine and B vitamins in mild cognitive impairment and dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F17482960902919360

Homocysteine and levodopa: should Parkinson disease patients receive preventative therapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F17482960902919360

Regulation of extracellular signal-regulated kinase by homocysteine in hippocampus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F17482960902919360

Perturbations in homocysteine-linked redox homeostasis in a murine model for hyperhomocysteinemia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F17482960902919360

Homocysteine-induced brain lipid peroxidation: effects of NMDA receptor blockade, antioxidant treatment, and nitric oxide synthase inhibition.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F17482960902919360

Mechanisms of homocysteine neurotoxicity in neurodegenerative diseases with special reference to dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F17482960902919360

Amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F17482960902919360

Homocysteine induces oxidative cytotoxicity in Cu,Zn-superoxide dismutase mutant motor neuronal cell

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F17482960902919360

Immunohistochemical study on the distribution of homocysteine in the central nervous system of transgenic mice expressing a human Cu/Zn SOD mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F17482960902919360

Reactive astrocytes express PARP in the central nervous system of SOD(G93A) transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F17482960902919360

Folate deficiency and homocysteine induce toxicity in cultured dorsal root ganglion neurons via cytosolic calcium accumulation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F17482960902919360

DL-Homocysteic acid application disrupts calcium homeostasis and induces degeneration of spinal motor neurons in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F17482960902919360

Folic acid protects motor neurons against the increased homocysteine, inflammation and apoptosis in SOD1 G93A transgenic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F17482960902919360

Recent advances in amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F17482960902919360

Elevated plasma homocysteine levels in patients with amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F17482960902919360

Homocysteine determinants and the evidence to what extent homocysteine determines the risk of coronary heart disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F17482960902919360

Transgenic SOD1 G93A mice develop reduced GLT-1 in spinal cord without alterations in cerebrospinal fluid glutamate levels

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F17482960902919360

Decreased glutamate transport by the brain and spinal cord in amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F17482960902919360

Complexity of astrocyte-motor neuron interactions in amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F17482960902919360

Emerging disease-modifying therapies for the treatment of motor neuron disease/amyotropic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F17482960902919360

Molecular and synaptic changes in the hippocampus underlying superior spatial abilities in pre-symptomatic G93A+/+ mice overexpressing the human Cu/Zn superoxide dismutase (Gly93 --> ALA) mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F17482960902919360

Cognitive function in bulbar- and spinal-onset amyotrophic lateral sclerosis. A longitudinal study in 52 patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F17482960902919360

Prognosis in amyotrophic lateral sclerosis: a population-based study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F17482960902919360

Methylenetetrahydrofolate reductase C677T genotype and PD.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F17482960902919360

Mechanisms of homocysteine toxicity in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F17482960902919360

Genetics of sporadic amyotrophic lateral sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F17482960902919360

Two types of seizures in homocysteine thiolactone-treated adult rats, behavioral and electroencephalographic study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F17482960902919360

Interaction between PON1 and population density in amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F17482960902919360

A common haplotype within the PON1 promoter region is associated with sporadic ALS.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F17482960902919360

Paraoxonase 1 (PON1) organophosphate hydrolysis is not reduced in ALS.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F17482960902919360

Paraoxonase promoter and intronic variants modify risk of sporadic amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F17482960902919360

Poly(ADP-ribose) polymerase: killer or conspirator? The 'suicide hypothesis' revisited

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F17482960902919360

Hyperhomocysteinemia and immune activation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F17482960902919360

Homocysteine accumulates in supernatants of stimulated human peripheral blood mononuclear cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F17482960902919360

Elevated IL-6 and TNF-alpha levels in patients with ALS: inflammation or hypoxia?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F17482960902919360

Elevated levels of homocysteine compromise blood-brain barrier integrity in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F17482960902919360

Homocysteine levels and decline in physical function: MacArthur Studies of Successful Aging

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F17482960902919360

Cross-sectional association between homocysteine and motor function in the elderly.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F17482960902919360

Elevated plasma homocysteine concentration in elderly patients with mental illness is mainly related to the presence of vascular disease and not the diagnosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F17482960902919360

Association of homocysteine with plasma amyloid beta protein in aging and neurodegenerative disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F17482960902919360

10.3109/17482960902919360

21 January 2018

Identifiers

DOI

1 reference

20 August 2017

1 reference